GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2010

NextGen to Develop Biomarker Assays for Takeda’s Research

  • NextGen Sciences will develop validated protein biomarker assays to be used in Takeda Pharmaceutical’s preclinical and clinical studies, supporting its drive toward personalized medicine.

    The biomarker assays will be designed to target specific protein isoforms found in the liver and muscle of multiple species for use in preclinical studies. The assays will also be validated for use in clinical studies. NextGen Sciences reports that its Multiple Reaction Monitoring protein assay platform is useful for studies of this kind, which involve multiple isoforms and multiple species.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?